Management of Plavix and Aspirin Before Hip Joint Corticosteroid Injection
For a hip joint corticosteroid injection, aspirin can be continued throughout the perioperative period, but clopidogrel (Plavix) should be stopped 5 days before the procedure. 1
Clopidogrel (Plavix) Management
The FDA label for Plavix explicitly states that therapy should be interrupted for 5 days prior to surgery with a major risk of bleeding, and this should be resumed as soon as hemostasis is achieved 1. This 5-day window is critical because:
- Clopidogrel irreversibly inhibits platelet aggregation for the lifetime of the platelet (7-10 days) 1
- The active metabolite has a short half-life, but the antiplatelet effect persists
- Five days allows sufficient turnover of platelets to restore adequate hemostasis
The 2022 ACCP guidelines support this approach, recommending P2Y12 inhibitor discontinuation with the last intake 5 days before surgery for clopidogrel 2. This timing is based on substantial evidence showing that clopidogrel continuation within 5 days of procedures increases major bleeding risk by approximately 50% and transfusion requirements by 70% 3.
Aspirin Management
Aspirin should be continued for hip joint injections. The evidence strongly supports continuation of aspirin in most perioperative settings:
- The 2022 ACCP guidelines demonstrate that aspirin continuation does not significantly increase bleeding complications in most surgical contexts 3
- The ATACAS trial showed no increased risk of reoperation for bleeding with perioperative aspirin use 3
- Aspirin discontinuation increases cardiovascular thrombotic risk, which typically outweighs bleeding concerns for most procedures 3, 2
For a hip joint corticosteroid injection specifically—which is a relatively low-bleeding-risk procedure compared to major surgery—aspirin continuation is appropriate and safer than the thrombotic risk of discontinuation.
Timing Considerations for the Injection Itself
While managing antiplatelet therapy, consider that corticosteroid injections within 3 months before total hip arthroplasty increase periprosthetic joint infection risk (HR 2.63) 4. If the patient is a surgical candidate, coordinate injection timing with potential surgical dates. However, this infection risk consideration is separate from the antiplatelet management question.
Resumption After Injection
Resume clopidogrel within 12-24 hours after the injection once adequate hemostasis is confirmed 2, 5. The FDA label emphasizes that discontinuation of Plavix increases cardiovascular event risk, so it should be restarted as soon as safely possible 1.
Aspirin, having been continued throughout, requires no resumption planning.
Key Caveats
- Do not bridge with heparin or LMWH: Bridging antiplatelet therapy with anticoagulants does not protect against coronary or stent thrombosis and actually increases bleeding risk 5
- Assess thrombotic risk: If the patient has a recent acute coronary syndrome, recent stent placement (especially drug-eluting stents), or other high thrombotic risk, consult cardiology before stopping clopidogrel—the thrombotic risk may outweigh bleeding concerns even for the injection 2, 5
- Ultrasound guidance: Use ultrasound guidance for the hip injection to increase accuracy and reduce procedural complications 6